Adam Greenstein is a doctor specialising in high blood pressure (hypertension), general (internal) medicine and geriatrics at Manchester Royal Infirmary. In addition, he is a clinician-scientist at the University of Manchester and a Professor of Pharmacology at the University of Vermont, USA. Adam researches small artery physiology and how damage to small arteries leads to dementia, hypertension and other ‘microvascular’ disorders.
Adam trained in medicine at Manchester, also completing a degree in Pharmacology. After completing junior doctor training in Yorkshire, Adam returned to Manchester for his PhD, funded with a personal fellowship from the European Society for Hypertension. Adam was then awarded a British Heart Foundation (BHF) Travel Fellowship to study with Professor Mark Nelson at the University of Vermont (2011-2012) and on his return to Manchester was awarded a BHF Intermediate Clinical Fellowship (2013-2016) to continue his work. Adam has published his work in almost all the world’s top cardiovascular journals: Circulation, Circulation Research, Hypertension and Journal of the American College of Cardiology. In 2021, his paper was awarded ‘Best Basic Science paper’ by the American Heart Association (Hypertension). In addition, Adam regularly publishes in top US science journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Science Signaling. Over the past decade, Adam has raised over £5 million for his research into small artery physiology and disease.
Microvascular @ Manchester 